Re: RVNC/Botox-biosimilar info from today’s GS webcast
RVNC is eligible to receive $60-70M from MYL in clinical/regulatory milestones and as much as $250M in sales-based milestones. (These amounts are in addition to the $60M RVNC has already received from MYL.)
As far as I know, today is the first time RVNC has disclosed any details about the clinical/regulatory and sales-based milestones in this program.
Market Data 
Markets 
AI
